Affiliate-supportedIndependent editorialWe never sell medicationSee how
We don't sell, prescribe, or ship medication — we surface the real cash price for every path. Wegovy, Zepbound, Ozempic, Mounjaro, and compounded alternatives.
GLP1Zoom is an independent price-comparison site for GLP-1 weight-loss and diabetes medications in the US. It is not a pharmacy, not a telehealth provider and not a prescriber, and it is unaffiliated with any manufacturer or clinic. It publishes what each drug costs on every route — manufacturer self-pay, insurance with a savings card, and compounded — with the terms that decide which figure you actually pay. It is funded by affiliate commission from telehealth providers, which does not change your price.
Lowest published cash price
Updated July 2026Partner offers first — we earn a commission from those — then ranked by our editorial score — compare and start online in minutes.
Advertising disclosure: we may earn a commission if you sign up through these links, at no extra cost to you — it never affects our rankings. How we make money
Compare telehealth providers and GLP-1 medications — branded and compounded (compounded are not FDA-approved).
$149–$499/mo typical rangeTake the quizManufacturer-direct
Free tool
Reveal hidden dose-escalation fees and commitment minimums across our provider list. See your real 12-month total.
Calculate true costWhat we cover
We don't sell anything. We compare. Every recommendation cites dated sources; acquisition-cost data refreshes weekly and provider prices are re-verified quarterly.
Side-by-side comparison of independent telehealth providers — we earn affiliate commission, editorial ratings are independent of partnerships.
Weight loss
Compare cash-pay plans from Mochi, Form Health, Henry Meds, Ro and others. Sourced from public provider pricing pages.
Starting from
$199/mo
View comparisonType 2 diabetes
Providers prescribing Ozempic, Mounjaro, Rybelsus and Trulicity. Insurance and cash-pay comparison.
Starting from
$249/mo
View comparisonCompounded
Compounded semaglutide and tirzepatide via 503A/503B pharmacies. Lower price, important FDA caveats.
Starting from
$149/mo
View comparisonThese are independent telehealth providers — we earn affiliate commission when you sign up via partner links. Editorial ratings are independent of partnerships. Prices sourced from public provider pages and re-verified quarterly. Read our affiliate disclosure.
What the data says
15-22%
Average body-weight reduction
Semaglutide (Wegovy) ~15% at 68 weeks; tirzepatide (Zepbound) ~22% at 72 weeks (STEP-1, SURMOUNT-1).
70%
Lower cash cost via compounded
Compounded semaglutide telehealth $150-300/mo vs brand Wegovy ~$1,350/mo list price.
12
Telehealth providers compared
Ro, Hims, Henry Meds, Mochi, LifeMD, PlushCare, WeightWatchers Clinic, Found, Calibrate, Eden, SkinnyRx, Hers.
Illustrative aggregate based on published clinical trial outcomes. Individual results vary.
We are a comparison and reference site. We don't prescribe or ship medications.
01 · Prices
Cash prices, dosage tiers, shipping windows. Last verified May 2026. No login required.
Compare drugs02 · Reference
Ask about dosing, interactions, or side effects. Answers cite the FDA source. Not medical advice.
Ask the assistant03 · Providers
Partners reviewed monthly for state coverage, dosing flexibility, and cash-pay transparency.
See providersMost effective
Tirzepatide (Mounjaro, Zepbound). Clinical trials show 22.5% mean weight loss at 72 weeks. Compare partner pharmacy prices.
From $349/mo via partner network · Important safety information
Once weekly
Semaglutide (Wegovy, Ozempic). FDA-approved since 2017, with the most published evidence of any GLP-1. Once-weekly injection.
From $299/mo via partner network · Important safety information
Primary sources we cite
Authorities cited across our drug, condition, and pricing content — see each page's sources.
Manufacturer-direct option
Starting at $299/mo for the 2.5 mg starting dose bought directly from Eli Lilly; maintenance doses run $449/mo if each refill is purchased within 45 days (up to $699/mo without the refill schedule). Pricing varies by dose and pharmacy — confirm before purchase.
From research to first dose, typically under 7 days.
Answer 3 questions about your goals, insurance, and budget. We match you to the right medication + provider.
Start quizSee current pricing across telehealth providers (verified each cycle). FDA-approved brand or compounded — your choice. Filter by state, dosage, shipping speed.
See providersUse insurance lookup, manufacturer savings cards, and copay programs to minimize out-of-pocket cost.
Check coverageYour chosen provider runs the telehealth eval, writes the Rx, and ships to your door — not GLP1Zoom. Most partner providers offer same-week start.
Get startedApproximate cash-pay starting prices across provider partners. Prices subject to change — confirm with each provider before purchase.
| Medication | Type | Lowest price | List price (WAC) |
|---|---|---|---|
| ZepboundBest deal | GIP/GLP-1 | $299/mo (2.5 mg starter) | $1086 |
| Wegovy | GLP-1 | $199/mo (introductory) | $1349 |
| Ozempic | GLP-1 | $199/mo (introductory) | $969 |
| Mounjaro | GIP/GLP-1 | See cost paths | $1069 |
Reference prices only — starter/introductory manufacturer cash prices; maintenance doses cost more (Zepbound $449/mo (7.5 mg and up)[zepbound] with 45-day refills, Wegovy ~$349/mo for maintenance doses[novocare]). Verified 2026-07. GLP1Zoom does not sell medications; we connect users to provider partners via affiliate links.
Five questions. We'll rank the top 3 GLP-1s that match your goals, insurance, and clinical fit.
Step 1 of 5
Illustrative price comparisons built from manufacturer-published cash-pay programs — not user testimonials. Your price depends on drug, dose, insurance, and eligibility.
Wegovy without insurance
~$1,349/mo list → ~$349/mo
NovoCare Pharmacy cash self-pay: ~$349/mo maintenance ($199/mo introductory) vs the ~$1,349/mo list price.
Zepbound self-pay vials
~$1,086/mo list → $299–$699/mo
LillyDirect single-dose vials run $299–$699/mo by dose vs the ~$1,086/mo list price.
Oral Wegovy pill
$149/mo cash
The oral semaglutide pill launched at $149/mo cash — below every injectable brand cash path.
$650/mo
Typical modeled saving: retail GLP-1 (~$1,000/mo) vs the lowest partner cash price (~$349/mo).
Illustrative only — your actual saving depends on drug, dose, and insurance.
How we model savings850+
State × drug pages
50
US states covered
12
Telehealth providers
18
GLP-1 medications
General pharmacy-coupon sites compare retail prices. Telehealth providers sell direct. GLP1Zoom is the only GLP-1-specialist comparison + tool layer.
| Feature | GLP1Zoom recommended | Telehealth (direct) |
|---|---|---|
| GLP-1 specialist | ~ | |
| Compare providers side-by-side | ||
| AI Q&A trained on FDA labels | ||
| Live FDA enforcement monitoring | ||
| Insurance lookup across plans | ||
| Drug interaction checker | ||
| Price history charts (90d, 1y) | ||
| US price heat map by state | ||
| Bariatric surgery comparison | ||
| Sourced to FDA labels + clinical trials | ~ | |
| Free, no signup |
Prices last verified May 2026, which is over three months ago — treat them as a starting point and confirm the current figure on the provider’s own site.
An independent price-comparison site for GLP-1 weight-loss and diabetes medications in the United States. It publishes what each drug costs on every route — manufacturer self-pay, commercial insurance with a savings card, and compounded — alongside the terms that decide which figure you actually pay. It is not affiliated with Novo Nordisk, Eli Lilly, or any telehealth provider, and it is not a clinic with the word Zoom in its name.
No. It is not a pharmacy, not a telehealth provider and not a prescriber. It dispenses nothing, issues no coupons of its own, and holds no patient records. Every price it publishes is a figure the manufacturer or provider published themselves, and every prescription decision belongs to a licensed clinician.
Affiliate commission. When a reader signs up with a telehealth provider through a link here, that provider pays a referral fee. It does not change the price the reader pays, and it is disclosed on every page carrying such a link. Manufacturer programmes — savings cards, self-pay pricing — earn nothing at all; they are listed because leaving them out would misrepresent the cheapest routes.
Manufacturer prices are read from the companies’ own published pages and held in one canonical module, so a correction updates every page at once rather than page by page. Provider prices are the figures each provider publishes, with the date they were last verified shown beside them. Compounded ranges span the providers listed here. Nothing is estimated, and where a figure could not be verified it is absent rather than guessed.
No, and the confusion is understandable — several US healthcare businesses use the word Zoom. ZoomCare is a clinic chain with physical locations that prescribes GLP-1s; Zoom Medical Weight Loss and My Zoom Clinic are separate providers. GLP1Zoom treats none of them as affiliates: it is an independent comparison site and sees no patients.
Recently published
Metabolic syndrome and GLP-1s
No drug is approved to treat metabolic syndrome — it is a cluster, not an indication. What is approved, component by component, with the trial numbers.
What semaglutide actually costs
One molecule, four US brands, a range of roughly twenty to one. Every published figure and what decides which one applies to you.
How to get a GLP-1 for $25 — and when you cannot
Every manufacturer advertises the same number. The cap that decides whether you ever see it is almost never printed beside it.
Every weight-loss peptide, ranked by evidence
Sixteen compounds in four tiers. Including the one that failed its own obesity trial and is still sold for it, and the one that is not a peptide at all.
Medications
Check availability
dulaglutide
Check availability
exenatide ER
liraglutide
Check availability
semaglutide
PopularCheck availability
semaglutide
PopularIn stock via 10 providers
semaglutide
CompoundedIn stock via 6 providers
semaglutide (compounded)
PopularCheck availability
tirzepatide
PopularIn stock via 7 providers
tirzepatide
CompoundedIn stock via 6 providers
tirzepatide (compounded)
Scroll to see more. "In stock" reflects average partner availability; confirm current availability with each provider.
Providers
Editorial
Sulfur burps are one of the most viral GLP-1 complaints on TikTok and Reddit. Here is the digestive mechanism behind the rotten-egg smell, why delayed gastric emptying makes it worse, and the dietary patterns associated with relief.
GLP1Zoom is a comparison site for GLP-1 medications and telehealth providers. We don't prescribe, sell, or ship drugs ourselves. We earn affiliate commission when you sign up via partner providers.
18
medications
Live FDA monitoring
Every drug page (18 GLP-1 + GIP/GLP-1 products) checks FDA shortage and enforcement status on every load. Compounded options carry explicit disclaimers.
100%
sourced to primary evidence
FDA labels + clinical trials
Every clinical claim is sourced to FDA prescribing information and named clinical trials by our editorial team. See the Editorial Standards page for how we review.
$0
cost to readers
Free + no signup
All comparisons, calculators, and AI Q&A are free. No paywall, no credit card, no data sold to third parties.
Cheapest published prices
via Mochi Health
$79/mo
LOWESTvia Eden
$99/mo
via HealthRX
$99/mo
via Mochi Health
$129/mo
via Hers
$149/mo
via Hims
$149/mo
Snapshot of current partner-network cash-pay prices. Final price depends on dose, plan, and partner offer at signup — verify on the partner's website (direct redirect).
Honest about what we are
Quick check
FDA-label thresholds: BMI ≥30 (obesity) or ≥27 with a weight-related condition (hypertension, type 2 diabetes, sleep apnea). Eligibility is determined by your prescriber, not by this calculator.
No data leaves your browser. We don't store, send, or sell what you type here.
—
Informational only. Final eligibility is determined by a licensed clinician at the partner you choose — not by GLP1Zoom.
In 2025, picking a GLP-1 telehealth provider meant comparing 12+ partner offers across 50 state regulatory frameworks, with cash-pay prices ranging from $199 to $1,200 a month. Most comparison sites at the time either took partner placement fees that shaped rankings — or were affiliate sites that didn't say so loudly enough.
We started GLP1Zoom with two rules. One:editorial ratings would be independent of commission rate — every provider is scored against the same public rubric, and the ones we don't recommend carry no affiliate link at all. Two: the affiliate model would be disclosed in plain English on every partner card — not buried in a privacy policy.
We're a comparison site. We don't prescribe, dispense, or process payments — that's the partner's job. Our job is to line them up honestly, verify their prices monthly, and explain what GLP-1s actually do, in language a 9th-grader would follow.
If we ever drift from those rules, you'll see it in the corrections log. Email editorial@glp1zoom.com if you spot a drift.
US coverage
Click your state for partners that operate there. Coverage and pricing vary by state telehealth law — we verify monthly.
Coverage figures are aggregated across the GLP1Zoom partner network. Individual partner availability differs — check the partner's website for definitive state coverage.
Editorial standards
GLP1Zoom is an independent comparison site — not a pharmacy or medical provider, and we don't give medical advice. Here's how we keep the drug facts, prices, and claims on every page accurate and verifiable.
Drug facts — approvals, dosing, and boxed warnings — are taken from current FDA prescribing information, not summarized from memory.
Prices, news, and coverage carry a last-reviewed date, and we re-check time-sensitive claims rather than let them go stale.
Clinical claims cite the trial or journal (with DOI) or the FDA/CMS source, so you can verify them yourself.
GLP1Zoom is an independent comparison site, not a pharmacy or clinician. Nothing here is medical advice or an endorsement of a partner provider.
Read more in our Editorial Policy · review & sourcing standards.
The GLP1Zoom weekly
Weekly editorial round-up — partner price changes, new FDA labels, drug-shortage updates, and one independent take. No medical advice; no spam.
Every clinical claim is sourced to FDA prescribing information and named clinical trials by our editorial team. Pricing is re-verified with each provider. Compounded medication content carries explicit FDA disclaimers.
